Lise Retat

1.4k total citations · 1 hit paper
32 papers, 619 citations indexed

About

Lise Retat is a scholar working on Nephrology, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Lise Retat has authored 32 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 9 papers in Economics and Econometrics and 6 papers in General Health Professions. Recurrent topics in Lise Retat's work include Chronic Kidney Disease and Diabetes (12 papers), Dialysis and Renal Disease Management (10 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Lise Retat is often cited by papers focused on Chronic Kidney Disease and Diabetes (12 papers), Dialysis and Renal Disease Management (10 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Lise Retat collaborates with scholars based in United Kingdom, United States and Sweden. Lise Retat's co-authors include Abbygail Jaccard, Laura Webber, Juan José García Sánchez, Claudia Cabrera, Salvatore Barone, Laura Pimpin, Kwan‐Dun Wu, Guisen Li, Panagiotis Stafylas and Paul Aveyard and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lise Retat

30 papers receiving 609 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme

2023 115 citations Vivekanand Jha, Saeed Alghamdi et al. Advances in Therapy profile →

Peers

Countries citing papers authored by Lise Retat

Since Specialization

Citations

This map shows the geographic impact of Lise Retat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise Retat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise Retat more than expected).

Fields of papers citing papers by Lise Retat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lise Retat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise Retat. The network helps show where Lise Retat may publish in the future.

Co-authorship network of co-authors of Lise Retat

This figure shows the co-authorship network connecting the top 25 collaborators of Lise Retat. A scholar is included among the top collaborators of Lise Retat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lise Retat. Lise Retat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Projection of the Prevalence and Economic Burden of Chronic Kidney Disease in Taiwan From 2022 to 2027 (Inside CKD): A Microsimulation Study 2025 ·Nephrology ·I‐Wen Wu, Mei‐Yi Wu, Salvatore Barone, Claudia Cabrera, Juan José García Sánchez, Lise Retat, (unknown), Kwan‐Dun Wu	1
2	Inside CKD: Cost-Effectiveness of Multinational Screening for CKD 2025 ·Kidney International Reports ·Navdeep Tangri, Kook‐Hwan Oh, Jason Choo, Michel Jadoul, Johan Ärnlöv, Marcelo Costa Batista, Christian Fynbo Christiansen, Gil Chernin, Lise Retat, (unknown), (unknown), Salvatore Barone, Stephen Nolan, Juan José García Sánchez	1
3	Long-term health consequences and costs of changes in alcohol consumption in England during the COVID-19 pandemic 2025 ·PLoS ONE ·(unknown), Sadie Boniface, Jamie Brown, Loren Kock, Alexander M. Martin, Lise Retat, (unknown)	2
4	Projecting the Population Level Burden of CKD Progression According to Urine Albumin-to-Creatinine Ratio Categories 2024 ·Kidney International Reports ·Luca De Nicola, Ricardo Correa-Rotter, Juan F. Navarro‐González, Albert Power, Michał Nowicki, István Wittmann, Jean‐Michel Halimi, Juan José García Sánchez, Claudia Cabrera, Salvatore Barone, (unknown), Lise Retat	5
5	Inside CKD: a microsimulation modelling study projects the clinical and economic burden of chronic kidney disease in Hungary 2024 ·SHILAP Revista de lepidopterología ·Lilla Szabó, (unknown), (unknown), Juan José García Sánchez, Salvatore Barone, Claudia Cabrera, Lise Retat, Laura Webber, István Wittmann, Boglárka Laczy	1
6	Inside ANEMIA of CKD: Projecting the Future Burden of Anemia of Chronic Kidney Disease and Benefits of Proactive Management: A Microsimulation Model of the Chinese Population 2024 ·Advances in Therapy ·Lise Retat, (unknown), Laura Webber, Alexander M. Martin, (unknown), (unknown), Yuzheng Zhang, (unknown), Juan José García Sánchez, Claudia Cabrera, (unknown), (unknown), Yiqing Wu, Li Zuo, (unknown)	0
7	Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study 2024 ·EClinicalMedicine ·Glenn M. Chertow, Ricardo Correa‐Rotter, Kai‐Uwe Eckardt, Eiichiro Kanda, Avraham Karasik, Guisen Li, Christian Fynbo Christiansen, Panagiotis Stafylas, S. Holt, E. Christiaan Hagen, Juan José García Sánchez, Salvatore Barone, Claudia Cabrera, Stephen Nolan, (unknown), Laura Webber, Lise Retat	17
8	Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study 2024 ·Rheumatology and Therapy ·(unknown), Lise Retat, (unknown), Brad A. Marder, Lissa Padnick‐Silver, Brian LaMoreaux, (unknown)	3
9	Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study 2023 ·Journal of Hepatology ·Lise Retat, (unknown), Peter Jepsen, Alexander M. Martin, Helena Cortez‐Pinto, Jeffrey V. Lazarus, Francesco Negro, (unknown), (unknown), (unknown), (unknown), Pierre Nahon, Nick Sheron, Shira Zelber‐Sagi, Marı́a Buti	17
10	Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme breakdown → 2023 ·Advances in Therapy ·Vivekanand Jha, Saeed Alghamdi, Guisen Li, Kwan‐Dun Wu, Panagiotis Stafylas, Lise Retat, (unknown), Salvatore Barone, Claudia Cabrera, Juan José García Sánchez	115
11	The future health and economic burden of obesity-attributable type 2 diabetes and liver disease among the working-age population in Saudi Arabia 2022 ·PLoS ONE ·(unknown), J. E. Saxton, Lise Retat, Khalid Alswat, Suliman Alghnam, Rajaa Al‐Raddadi, Habeeb Ibrahim Abdul Razack, Laura Webber, Saleh A. Alqahtani	17
12	POS-323 INSIDE CKD: PROJECTING THE FUTURE BURDEN OF CHRONIC KIDNEY DISEASE IN EUROPE USING MICROSIMULATION MODELLING 2021 ·Kidney International Reports ·Juan José García Sánchez, Albert Power, (unknown), Johan Ärnlöv, Claudia Cabrera, Luca De Nicola, Jean‐Michel Halimi, F.S. Mennini, Juan F. Navarro‐González, (unknown), Lise Retat, Laura Webber, (unknown)	3
13	Screening and brief intervention for obesity in primary care: cost-effectiveness analysis in the BWeL trial 2019 ·International Journal of Obesity ·Lise Retat, Laura Pimpin, Laura Webber, Abbygail Jaccard, Amanda Lewis, Sarah Tearne, Kathryn E. Hood, (unknown), Peymané Adab, Rachna Begh, Kate Jolly, Amanda Daley, Amanda Farley, Deborah Lycett, Alecia Nickless, Ly‐Mee Yu, Susan A. Jebb, Paul Aveyard	23
14	Estimating the costs of air pollution to the National Health Service and social care: An assessment and forecast up to 2035 2018 ·PLoS Medicine ·Laura Pimpin, Lise Retat, Daniela Fecht, Laure de Preux, Franco Sassi, John Gulliver, Annalisa Belloni, Brian Ferguson, Emily Corbould, Abbygail Jaccard, Laura Webber	64
15	Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation 2018 ·Health Technology Assessment ·Alison Avenell, Clare Robertson, Zoë Skea, Elisabet Jacobsen, Dwayne Boyers, David Cooper, Magaly Aceves‐Martins, Lise Retat, Cynthia Fraser, Paul Aveyard, Fiona Stewart, Graeme MacLennan, Laura Webber, Emily Corbould, (unknown), Abbygail Jaccard, (unknown), Eilidh Duncan, Michal Shimonovich, Marijn de Bruin	60
16	Modelling the implications of reducing smoking prevalence: the public health and economic benefits of achieving a ‘tobacco-free’ UK 2017 ·Tobacco Control ·Daniel Hunt, (unknown), Abbygail Jaccard, (unknown), Lise Retat, (unknown), Katrina Brown, (unknown), Martin Brown	14
17	Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial 2017 ·The Lancet ·Amy L. Ahern, Graham Wheeler, Paul Aveyard, E. Boyland, Jason C. G. Halford, Adrian Mander, (unknown), Ann Thomson, Melina Tsiountsioura, Darren Cole, Bethan R. Mead, Lisa Irvine, David Turner, Marc Suhrcke, Laura Pimpin, Lise Retat, Abbygail Jaccard, Laura Webber, Simon Cohn, Susan A. Jebb	155
18	Modelling the implications of reducing smoking prevalence: the benefits of increasing the UK tobacco duty escalator to public health and economic outcomes 2017 ·Tobacco Control ·(unknown), Daniel Hunt, Abbygail Jaccard, (unknown), Martin Brown, Lise Retat, Katrina Brown, Sebastian Hinde, (unknown), Linda Bauld, (unknown)	21
19	The cost-effectiveness of population Health Checks: have the NHS Health Checks been unfairly maligned? 2017 ·Journal of Public Health ·Sebastian Hinde, Laura Bojke, Gerry Richardson, Lise Retat, (unknown)	12
20	"Modeling the Long-Term Health and Cost Impacts of Reducing Smoking Prevalence through Tobacco Taxation in Ukraine." 2017 ·(unknown), (unknown), (unknown), Abbygail Jaccard, Lise Retat, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact